(Q44397466)

2 December 2017

Serum soluble TNF receptor I and II levels correlate with disease activity in IBD patients (English)

1 reference

2 December 2017

0 references

9

Gerhard Rogler

1 reference

2 December 2017

Tanja Spoettl

1

1 reference

2 December 2017

Martin Hausmann

2

1 reference

2 December 2017

Frank Klebl

3

1 reference

2 December 2017

Andrea Dirmeier

4

1 reference

2 December 2017

Bodo Klump

5

1 reference

2 December 2017

Joerg Hoffmann

6

1 reference

2 December 2017

Hans Herfarth

7

1 reference

2 December 2017

Antje Timmer

8

1 reference

2 December 2017

1 June 2007

1 reference

Inflammatory Bowel Diseases

2 December 2017

1 reference

2 December 2017

13

1 reference

2 December 2017

6

1 reference

2 December 2017

727-732

1 reference

Imbalance of the interleukin 1 system in colonic mucosa--association with intestinal inflammation and interleukin 1 receptor antagonist [corrected] genotype 2.

2 December 2017

1 reference

Cytokines in inflammatory bowel disease

21 January 2018

1 reference

Secretion imbalance between tumour necrosis factor and its inhibitor in inflammatory bowel disease

21 January 2018

1 reference

Tumor necrosis factor/tumor necrosis factor receptor family members that positively regulate immunity

21 January 2018

1 reference

TNF pathophysiology in murine models of chronic inflammation and autoimmunity.

21 January 2018

1 reference

Modulation of TNF receptor family members to inhibit autoimmune disease

21 January 2018

1 reference

The TNF-TNF receptor system

21 January 2018

1 reference

Autoimmunity and anti-TNF-alpha agents

21 January 2018

1 reference

TNF-alpha antagonists for the treatment of Crohn's disease

21 January 2018

1 reference

Infliximab for the treatment of fistulas in patients with Crohn's disease

21 January 2018

1 reference

Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease.

21 January 2018

1 reference

Infliximab and ulcerative colitis.

21 January 2018

1 reference

Infliximab induces potent anti-inflammatory responses by outside-to-inside signals through transmembrane TNF-alpha

21 January 2018

1 reference

Shedding of tumor necrosis factor receptors by activated human neutrophils

21 January 2018

1 reference

Release of full-length 55-kDa TNF receptor 1 in exosome-like vesicles: a mechanism for generation of soluble cytokine receptors

21 January 2018

1 reference

TNF/TNFR family members in costimulation of T cell responses

21 January 2018

1 reference

Up-regulation of soluble tumor necrosis factor receptor two in plasma of HIV-seropositive individuals who use opiates.

21 January 2018

1 reference

Preconditioning up-regulates the soluble TNF receptor I response to endotoxin.

21 January 2018

1 reference

TNF and TNFR polymorphisms in severe sepsis and septic shock: a prospective multicentre study

21 January 2018

1 reference

Etanercept treatment in the endotoxin-induced uveitis of rats.

21 January 2018

1 reference

Outcome of patients with active ankylosing spondylitis after two years of therapy with etanercept: clinical and magnetic resonance imaging data

21 January 2018

1 reference

Treatment of steroid-resistant acute graft-versus-host disease with daclizumab and etanercept

21 January 2018

1 reference

Pilot trial on the use of etanercept and methylprednisolone as primary treatment for acute graft-versus-host disease.

21 January 2018

1 reference

The treatment of psoriasis with etanercept

21 January 2018

1 reference

Treatment of myositis with etanercept (Enbrel), a recombinant human soluble fusion protein of TNF-alpha type II receptor and IgG1.

21 January 2018

1 reference

Etanercept treatment of renal amyloidosis complicating rheumatoid arthritis

21 January 2018

1 reference

21 January 2018

Etanercept in arthritis

1 reference

21 January 2018

Etanercept in psoriasis

1 reference

Soluble tumour necrosis factor receptors p55 and p75 in the urine monitor disease activity and the efficacy of treatment of inflammatory bowel disease

21 January 2018

1 reference

Profile of soluble cytokine receptors in Crohn's disease

21 January 2018

1 reference

Tumour necrosis factor α and interleukin 1β in relapse of Crohn's disease

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IBD.20107

1 reference

2 December 2017

1 reference